NYSE:RMDMedical Equipment
Is ResMed’s (RMD) Hardware-Led Margin Strength Quietly Redefining Its Software-Driven Narrative?
In the past few days, ResMed reported largely positive fiscal second-quarter 2026 results, with strength in its Masks & Accessories and Devices segments offsetting softer performance in its Software as a Service business.
Analysts highlighted improving margins and operating leverage across ResMed’s core hardware operations, underlining how the company’s earnings profile is being shaped by product mix and cost efficiencies rather than software growth alone.
Now we’ll explore how stronger...